BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Sunday, June 14, 2026
Home » Topics » Disease categories and therapies » Orthopedics

Orthopedics
Orthopedics RSS Feed RSS

BioWorld MedTech’s Orthopedics Extra for April 8, 2020

April 8, 2020
By Holland Johnson
Keeping you up to date on recent developments in orthopedics, including: Excess weight during pre-school linked to higher bone fracture risk; Cells must age for muscles to regenerate in muscle-degenerating diseases; COVID-19 pandemic may exacerbate childhood obesity.
Read More
X-Ray showing scoliosis

Orthopediatrics unveils deal to buy Apifix to gain MID-C system

April 2, 2020
By Liz Hollis
Warsaw, Ind.-based Orthopediatrics Corp. is scooping up Apifix Ltd., allowing it to gain the Minimally Invasive Deformity Correction (MID-C) system, which is used to treat adolescent idiopathic scoliosis. BTIG’s Ryan Zimmerman noted that the deal has a potential value of $67 million plus potential future revenue milestones. “The initial upfront payment has a ~$37 [million] value, composed of $2 million in cash and ~935k shares of common stock,” he added.
Read More

BioWorld MedTech’s Orthopedics Extra for April 1, 2020

April 1, 2020
By Holland Johnson
Keeping you up to date on recent developments in orthopedics, including: Individuals taking class of steroid medications at high risk for COVID-19; Broken bone location can have significant impact on long-term health; (Re)generation next: Novel strategy to develop scaffolds for joint tissue regeneration.
Read More

BioWorld MedTech’s Orthopedics Extra for March 25, 2020

March 25, 2020
By Holland Johnson
Keeping you up to date on recent developments in orthopedics, including: First glimpse of body's 'steering wheel' joint sparks hope; Using CRISPR to find muscular dystrophy treatments; Fracture liaison service improves care for patients with fragility fractures.
Read More

BioWorld MedTech’s Orthopedics Extra for March 18, 2020

March 18, 2020
By Holland Johnson
Keeping you up to date on recent developments in orthopedics, including: Vitamin D boosts chances of walking after hip fracture; Rsip Vision reports breakthrough AI tech for 3D reconstruction of knees; Study shows disparities in outpatient care for common orthopedic problems.
Read More

BioWorld MedTech’s Orthopedics Extra for March 11, 2020

March 11, 2020
By Holland Johnson
Keeping you up to date on recent developments in orthopedics, including: Artificial intelligence can scan doctors' notes to distinguish between types of back pain; Researchers discover new stem cells that can generate new bone; Study shows improved outcomes for patients with Arthrosurface Ovo arthroplasty system.
Read More

Ziptek develops novel orthopedic fixation device

March 10, 2020
By Sergio Held
BOGOTA, Colombia – Ziptek Mexico, from Hermosillo, Mexico, is working to revolutionize the sutures market with an innovative product that is already making its way to the U.S. surgical orthopedic device market. Plans to expand across Latin America are progressing.
Read More

BioWorld MedTech’s Orthopedics Extra for March 4, 2020

March 4, 2020
By Holland Johnson
Keeping you up to date on recent developments in orthopedics, including: Researchers identify protein critical for wound healing after spinal cord injury; Journal publishes results of Gid Bio trial for treating osteoarthritis knee pain; Study maps landmarks of peripheral artery disease to guide treatment development.
Read More

BioWorld MedTech’s Orthopedics Extra for Feb. 26, 2020

Feb. 26, 2020
By Holland Johnson
Keeping you up to date on recent developments in orthopedics, including: Bone or cartilage? Presence of fatty acids determines skeletal stem cell development; A promising new strategy to help broken bones heal faster; Drug cocktail holds promise for spinal injuries.
Read More
Orthopedics implants, joint-replacements

CMS adds three years to joint replacement demo, but device makers at low risk

Feb. 21, 2020
By Mark McCarty
The U.S. Centers for Medicare and Medicaid Services (CMS) announced it may tack on another three years to the Comprehensive Care for Joint Replacement (CJR) program, proposing among other things to drop the 50% cap on gainsharing payments. Analysts with Cowen Washington Research Group, of New York, said post-acute care providers are at greater risk than device makers with the extension, however, due to the fact that hospitals have several choices in terms of discharge destination, including the patient’s home.
Read More
Previous 1 2 … 22 23 24 25 26 27 28 29 30 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 12, 2026.
  • Purple molecules

    Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis

    BioWorld
    Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
  • Neck exam

    Ethyreal launches to treat the underlying cause of Graves’, TED

    BioWorld
    Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
  • 3D illustration of a nerve cell

    Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?

    BioWorld
    Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
  • Jiangsu Nhwa Pharmaceutical patents new κ-opioid receptor antagonists

    BioWorld Science
    Jiangsu Nhwa Pharmaceutical Co. Ltd. has disclosed κ-opioid receptor antagonists that are potentially useful for the treatment of neurological disorders.
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing